Who owns MIRUM PHARMACEUTICALS INC NOTE 4.000 5/0?
- CUSIP Number: 604749ab7
Tip: Access positions for across all investors
Analyze quarterly positions in Mirum Pharmaceuticals Inc Note 4.000 5/0 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Mirum Pharmaceuticals Inc Note 4.000 5/0 stock
Who bought or sold MIRUM PHARMACEUTICALS INC NOTE 4.000 5/0 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deerfield Management Company | 70M | $168M | 0% | Sep 2025 |
|
| Readystate Asset Management | 30M | $73M | -10% | Sep 2025 |
|
| MacKay Shields | 26M | $63M | -6% | Sep 2025 |
|
| Tenor Capital Management | 25M | $61M | 100% | Sep 2025 |
|
| Citadel Advisors | 24M | $59M | 9% | Sep 2025 |
|
| Franklin Resources | 24M | $59M | -1% | Sep 2025 |
|
| Polar Securities | 21M | $52M | 100% | Sep 2025 |
|
| Capstone Investment Advisors | 19M | $46M | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 9.8M | $24M | 72% | Sep 2025 |
|
| Point72 Asset Management | 9.4M | $23M | 0% | Sep 2025 |
|
| FMR | 6.1M | $15M | -7% | Sep 2025 |
|
| Aristeia Capital | 6.0M | $14M | 0% | Sep 2025 |
|
| Aequim Alternative Investments | 6.0M | $14M | 0% | Sep 2025 |
|
| SSI Investment Management | 5.6M | $14M | -12% | Sep 2025 |
|
| Lord, Abbett & Co | 4.0M | $9.6M | -13% | Sep 2025 |
|
| BlackRock | 3.0M | $7.3M | -2% | Sep 2025 |
|
| Nicholas Investments Partners | 3.0M | $7.2M | 33% | Sep 2025 |
|
| Invesco | 2.5M | $6.0M | 0% | Sep 2025 |
|
| Linden Advisors | 2.0M | $4.8M | 100% | Sep 2025 |
|
| Bank Of Montreal | 2.0M | $3.5M | 100% | Jun 2025 |
|
| Lazard Asset Management | 1.9M | $47k | -23% | Sep 2025 |
|
| Ameriprise Financial | 1.5M | $3.6M | -84% | Sep 2025 |
|
| Kornitzer Capital Management | 1.1M | $2.6M | -15% | Sep 2025 |
|
| Advent Capital Management | 1.1M | $2.6M | -19% | Sep 2025 |
|
| Kohlberg Kravis Roberts & Co | 894k | $2.2M | 0% | Sep 2025 |
|
| Agf Management | 700k | $1.7M | 0% | Sep 2025 |
|
| Wells Fargo & Company | 535k | $1.3M | -2% | Sep 2025 |
|
| Barclays | 358k | $860k | 3% | Sep 2025 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 237k | $574k | -20% | Sep 2025 |
|
| Sei Investments | 228k | $548k | 0% | Sep 2025 |
|
| Central Pacific Bank - Trust Division | 125k | $300k | -33% | Sep 2025 |
|
| Bank of New York Mellon | 100k | $237k | 100% | Sep 2025 |
|
| Nomura Holdings | 96k | $7.1M | 100% | Sep 2025 |
|
| Oppenheimer Asset Management | 64k | $154k | 3% | Sep 2025 |
|
| Morgan Stanley | 60k | $106k | 100% | Jun 2025 |
|
| Calamos Advisors | 31k | $75k | -28% | Sep 2025 |
|
| Stephens | 20k | $48k | 0% | Sep 2025 |
|
| Balboa Wealth Partners | 10k | $24k | 0% | Sep 2025 |
|
| Stonegate Investment Group | 10k | $24k | -17% | Sep 2025 |
|
| Fifth Third Bancorp | 4.0k | $961k | 100% | Sep 2025 |
|
| Steward Partners Investment Advisory | 1.0k | $2.4k | 0% | Sep 2025 |
|
| UBS Group | 670.00 | $1.6k | 103% | Sep 2025 |
|
Who sold out of Mirum Pharmaceuticals Inc Note 4.000 5/0?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Wolverine Asset Management | Jun 2025 | 47M | $84M |
| Royal Bank of Canada | Jun 2025 | 1.1M | $2.0M |
| 683 Capital Management | Jun 2025 | 1.0M | $1.8M |
| Context Capital Management | Jun 2025 | 18k | $32M |
| Raymond James Financial | Jun 2025 | 1.0k | $1.8k |